Numeric Investors’s Phio Pharmaceuticals PHIO Stock Holding History

Numeric Investors’s Portfolio PHIO Stock Details PHIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-1	Closed	-$1.4M	–	875
2014 Q1	$1.4M	Buy	+1	New	+$3.18M	0.02%	373

Other funds holding PHIO

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

SFM

Sphera Funds Management Tel Aviv, Israel $630M AUM 108.65% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

SIM

Spark Investment Management New York $41.6M AUM 80.97% 1-Year Est. Return

Numeric Investors's PHIO Position: Q2 2014 in Review

Numeric Investors sold out of Phio Pharmaceuticals (PHIO) in Q2 2014, closing a stake of 1 share — an estimated $1.4M sold.

Numeric Investors first reported a position in PHIO in Q1 2014 and held it in 1 quarter. The position peaked at $1.4M in Q1 2014. 1 fund tracked by Wall St. Rank holds PHIO as of Q2 2014.

Numeric Investors reported no remaining Phio Pharmaceuticals position as of Q2 2014 after selling out during the quarter.
Numeric Investors sold 1 Phio Pharmaceuticals share in Q2 2014, an estimated $1.4M.
Numeric Investors first reported a position in Phio Pharmaceuticals in Q1 2014 and held it in 1 quarter.
Numeric Investors's Phio Pharmaceuticals position peaked at $1.4M in Q1 2014.
1 fund tracked by Wall St. Rank held Phio Pharmaceuticals as of Q2 2014.

Based on Numeric Investors's 13F filing for Q2 2014, filed 11 Aug 2014.